|1.||Drummond, Grant R: 2 articles (07/2015 - 11/2012)|
|2.||Sobey, Christopher G: 2 articles (07/2015 - 11/2012)|
|3.||Dansereau, Marc-André: 2 articles (04/2011 - 07/2008)|
|4.||Sarret, Philippe: 2 articles (04/2011 - 07/2008)|
|5.||Pommier, Blandine: 2 articles (04/2011 - 07/2008)|
|6.||Mauborgne, Annie: 2 articles (04/2011 - 07/2008)|
|7.||Kitabgi, Patrick: 2 articles (04/2011 - 07/2008)|
|8.||Pohl, Michel: 2 articles (04/2011 - 07/2008)|
|9.||Broughton, Brad R S: 1 article (07/2015)|
|10.||Chu, Hannah X: 1 article (07/2015)|
07/01/2008 - "These pronociceptive effects of CCL2 are completely prevented by the selective CCR2 antagonist (INCB3344), indicating that CCL2-induced pain facilitation is elicited via direct spinal activation of CCR2 receptor. "
04/13/2011 - "These pathological pain-associated changes in the DHSC were mimicked by the intrathecal injection of exogenous CCL2 in naive rats and were prevented by the administration of INCB3344 or ERK inhibitor (PD98059). "
03/01/2014 - "By contrast, pre-emptive INCB3344 treatment delayed the emergence of trigeminal mechanical allodynia and associated biochemical alterations. "
04/13/2011 - "Finally, mechanical allodynia, which was fully developed 2 weeks after SN-CCI in rats, was attenuated by the intrathecal injection of INCB3344. "
07/01/2015 - "Ly6C(hi) monocytes were increased 3-fold in the blood and 10-fold in the brain after stroke, and these increases were selectively prevented by INCB3344 in a dose-dependent manner. "
07/01/2015 - "We used a selective CC chemokine receptor 2 antagonist, INCB3344, to assess the effect of Ly6C(hi) monocytes recruited into the brain early after ischemic stroke. "
|2.||Messenger RNA (mRNA)
|3.||Dimethyl Sulfoxide (DMSO)
|5.||Carboxymethylcellulose Sodium (Polycell)